3138 results for «714»

Filter By

3138 results

Rapid-fire clinical cases: Session 6

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of abstracts presented during PCR LV 2022: valve-in-valve implant in a dysfunctional tricuspid bioprosthesis, first patient in TRICURE FIH trial, challenging percutaneous closure of prosthetic paravalvular leaks, and more!

Rapid-fire clinical cases: Session 6

Rapid-fire clinical cases: Session 7

29 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: simultaneous transcatheter edge-to-edge repair of mitral and tricuspid valve, transcatheter valve implantation in mitral and tricuspid valve position, TEER failure in mitral and tricuspid position: troubleshooting approach for a rare but still eventful case,...

Rapid-fire clinical cases: Session 7

Clinical outcomes after TAVI: Session 2

29 Nov 2022 – From PCR London Valves 2022

Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!

Clinical outcomes after TAVI: Session 2

Complex CTOs in CHIP

14 Dec 2022 – From GulfPCR-GIM 2022

Watch this session if you want to understand when and how protected PCI with mechanical support in CHIP is needed. You'll also learn about complex CTO PCI treatment in both antegrade and retrograde approaches, and plaque debulking techniques in severe calcified lesions.

Complex CTOs in CHIP

How should I treat STEMI?

14 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, watch a series of STEMI cases and learn more about left main stem, bifurcation, imaging, large thrombus situation, and cardiogenic shock in this particular context and follow the ensuing discussions to be better prepared if you were ever faced with it yourself.

How should I treat STEMI?

Imaging in TAVI with challenging anatomy

14 Dec 2022 – From GulfPCR-GIM 2022

Through the 3 cases presented in this GulfPCR-GIM 2022 session and the highly informative discussion among your peers, learn how to use TAVI with difficult anatomies such as bicuspid aortic valves by relying on imaging.

Imaging in TAVI with challenging anatomy

Trial review 2022: my five most impactful clinical trials

14 Dec 2022 – From GulfPCR-GIM 2022

In this session of GulfPCR-GIM 2022, Andreas Baumbach has the honour of presenting the 5 clinical trials that he considers to be the most important of the year 2022. His choice is between trials that could change our practice, those that confirm it, certain guidelines, or...

Trial review 2022: my five most impactful clinical trials

TMVR challenges

27 Nov 2022 – From PCR London Valves 2022

Challenges in this session of PCR LV 2022 include hybrid valve implantation for mitral annular calcification, transcatheter double-valve implantation complicated by mitral bioprosthesis migration, and transcatheter transseptal mitral valve implantation. Watch now to find out more!

TMVR challenges

Tricuspid interventions

27 Nov 2022 – From PCR London Valves 2022

How to manage tricuspid valve disease in a patient with atrial fibrillation, transcatheter tricuspid valve repair with transthoracic echocardiography guidance, or a patient with severe tricuspid regurgitation with a novel transcatheter treatment? Watch this PCR LV 2022 session for answers!

Tricuspid interventions

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Top Late-Breaking Trials

Rapid-fire clinical cases: session 2

27 Nov 2022 – From PCR London Valves 2022

Discover in the same PCR LV 2022 session a TAVI for pure aortic regurgitation in degenerated aortic homograft, an embolised Myval transcatheter heart valve to AAA, or a challenging ViV TAVI, and much more!

Rapid-fire clinical cases: session 2

CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.

Tricuspid - Late-Breaking Trials

Rapid-fire abstracts: session 3

27 Nov 2022 – From PCR London Valves 2022

Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.

Rapid-fire abstracts: session 3

Mitral valve in mitral annular calcification (MAC) - Recorded case

27 Nov 2022 – From PCR London Valves 2022

A 53-year-old male with a history of SAVR (Perimount 23) 10 years ago and chest radiotherapy (lymphoma) presents a severe mitral stenosis (MAC) with preserved LV function and impaired RV function.
On sentinel cerebral protection, the operators perform a transseptal puncture with electrifying a non-stiff guide wire,...

Recorded case: Mitral valve in MAC

The multidisciplinary structural heart team - How do we include the patient

27 Nov 2022 – From PCR London Valves 2022

Consult this session on the multidisciplinary structural heart team to learn more about the evolving role of the team and how this affects decision making, to discover why patient advocacy and partnership is vital within the team, as well as to identify potential barriers and enablers of the future...

The multidisciplinary structural heart team - How do we include the patient

Patient selection for tricuspid valve interventions

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the anatomical assessment of candidates for transcatheter tricuspid valve interventions, to understand the importance of detailed haemodynamic assessment in patients with severe tricuspid regurgitation and to discuss the predictors of clinical outcome after these interventions.

Patient selection for tricuspid valve interventions

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn about the latest news in the field of mitral valve intervention and get insights into its current slow progress, which may be caused by clinical, anatomical or technological factors.

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

Is frailty still relevant after 20 years of TAVI?

28 Nov 2022 – From PCR London Valves 2022

Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.

Is frailty still relevant after 20 years of TAVI?

TAVI challenges: session 3

28 Nov 2022 – From PCR London Valves 2022

View a radial access balloon aortic valvuloplasty adapting to the challenge of small arteries, a semi-inflated buddy balloon for percutaneous TAVR in severe calcified bicuspid aortic valve, and long-term outcome of TAVR in mucopolysaccharidosis type I-HS in this PCR LV 2022 session, among others!

TAVI challenges: session 3

Surgical and transcatheter tricuspid intervention: state of the art - LIVE case

29 Nov 2022 – From PCR London Valves 2022

In this PCR London Valves 2022 session, follow 3 stunning case treatments:

  • Part 1: Triscupid TEER (Live)
    A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
    They performed...
Surgical and transcatheter tricuspid intervention: state of the art
Didn’t find what you were looking for?